Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in DystroglycanopathyKanagawa, Motoi; Toda, Tatsushi · Journal of Neuromuscular Diseases · 2017

TRPV2 is critical for the maintenance of cardiac structure and function in miceKatanosaka, Yuki; Iwasaki, Keiichiro; Ujihara, Yoshihiro; Takatsu, Satomi; Nishitsuji, Koki; Kanagawa, Motoi; Sudo, Atsushi; Toda, Tatsushi; Katanosaka, Kimiaki; Mohri, Satoshi; Naruse, Keiji · Nature Communications · 2014

Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expressionOhtsuka, Yoshihisa; Kanagawa, Motoi; Yu, Chih-Chieh; Ito, Chiyomi; Chiyo, Tomoko; Kobayashi, Kazuhiro; Okada, Takashi; Takeda, Shin'ichi; Toda, Tatsushi · Scientific Reports · 2015

Elimination of fukutin reveals cellular and molecular pathomechanisms in muscular dystrophy-associated heart failureUjihara, Yoshihiro; Kanagawa, Motoi; Mohri, Satoshi; Takatsu, Satomi; Kobayashi, Kazuhiro; Toda, Tatsushi; Naruse, Keiji; Katanosaka, Yuki · Nature Communications · 2019

Cell endogenous activities of fukutin and FKRP coexist with the ribitol xylosyltransferase, TMEM5Nishihara, Ryuta; Kobayashi, Kazuhiro; Imae, Rieko; Tsumoto, Hiroki; Manya, Hiroshi; Mizuno, Mamoru; Kanagawa, Motoi; Endo, Tamao; Toda, Tatsushi · Biochemical and Biophysical Research Communications · 2018

Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of α-dystroglycanHui Xiong; Kazuhiro Kobayashi; Masaji Tachikawa; Hiroshi Manya; Satoshi Takeda; Tomohiro Chiyonobu; Nobuhiro Fujikake; Fan Wang; Akemi Nishimoto; Glenn E. Morris; Yoshitaka Nagai; Motoi Kanagawa; Tamao Endo; Tatsushi Toda · 2006

CDP-glycerol inhibits the synthesis of the functional <i>O</i> -mannosyl glycan of α-dystroglycanImae, Rieko; Manya, Hiroshi; Tsumoto, Hiroki; Osumi, Kenji; Tanaka, Tomohiro; Mizuno, Mamoru; Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi; Endo, Tamao · Journal of Biological Chemistry · 2018